Holen Sie sich die Stockscreener-App
0.2493
4.73%
-0.0108
Schlusskurs vom Vortag:
$0.26
Offen:
$0.2504
24-Stunden-Volumen:
744.49K
Relative Volume:
0.06
Marktkapitalisierung:
$35.73M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-119.76M
KGV:
-0.1846
EPS:
-1.35
Netto-Cashflow:
$-55.17M
1W Leistung:
-4.10%
1M Leistung:
-78.46%
6M Leistung:
-29.89%
1J Leistung:
-87.80%
1-Tages-Spanne:
$0.2459
$0.2573
1-Wochen-Bereich:
$0.238
$0.266
52-Wochen-Spanne:
$0.2182
$2.09
Applied Therapeutics Inc Stock (APLT) Company Profile
Firmenname
Applied Therapeutics Inc
Sektor
Branche
Telefon
212-220-9226
Adresse
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Vergleichen Sie APLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.2476 | 37.52M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
430.07 | 110.02B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
778.96 | 82.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.76 | 59.61B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
894.41 | 56.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.50 | 44.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Eingeleitet | William Blair | Outperform |
| 2024-03-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-22 | Eingeleitet | Leerink Partners | Outperform |
| 2022-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Herabstufung | Goldman | Neutral → Sell |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2020-10-08 | Eingeleitet | Truist | Buy |
| 2020-04-22 | Eingeleitet | Goldman | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-06-10 | Eingeleitet | Citigroup | Buy |
| 2019-06-10 | Eingeleitet | Cowen | Outperform |
| 2019-06-10 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten
What analysts say about Applied Therapeutics Inc stockHead and Shoulders Patterns & Minimal Investment Trading - earlytimes.in
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - Yahoo Finance
Applied Therapeutics Reports Third Quarter 2025 Financial Results - ADVFN
Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options - MSN
Applied Therapeutics (APLT) Stock Price, Quote, News & History - Benzinga
Applied Therapeutics Investors Get 1st OK For $15M Deal - Law360
Why Applied Therapeutics Inc. stock could see breakout soonMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Applied Therapeutics explores strategic alternatives amid workforce cuts By Investing.com - Investing.com Nigeria
Applied Therapeutics Announces Corporate Updates - Investing News Network
Applied Therapeutics, Inc. Initiates Strategic Alternatives Review - TradingView
Applied Therapeutics explores strategic alternatives amid workforce cuts - Investing.com
APLT Evaluates Strategic Options as Workforce Reductions Announced - GuruFocus
APLT Evaluates FDA Meeting Outcomes for Govorestat Development P - GuruFocus
What data driven models say about Applied Therapeutics Inc.’s future - newser.com
Applied Therapeutics (Nasdaq: APLT) to Explore Strategic Alternatives, Reduce Workforce 46% - Stock Titan
Can Applied Therapeutics Inc. (2UV) stock surprise markets with earningsMarket Volume Report & High Win Rate Trade Tips - newser.com
Is Applied Therapeutics Inc. (2UV) stock prepared for digital transitionMarket Sentiment Review & Growth Focused Stock Pick Reports - newser.com
How Applied Therapeutics Inc. stock reacts to inflationary pressuresWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Can Applied Therapeutics Inc. (2UV) stock expand revenue streamsJuly 2025 Breakouts & Safe Swing Trade Setups - newser.com
Is Applied Therapeutics Inc. (2UV) stock a top pick for value investorsEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Why Applied Therapeutics Inc. (2UV) stock fits value portfoliosVolume Spike & Free Daily Entry Point Trade Alerts - newser.com
Applied Therapeutics Inc. stock daily chart insightsJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Does Applied Therapeutics Inc. show high probability of reboundJuly 2025 Earnings & Smart Investment Allocation Insights - newser.com
Statistical indicators supporting Applied Therapeutics Inc.’s strengthPortfolio Update Report & Low Drawdown Investment Strategies - newser.com
Analyzing Applied Therapeutics Inc. with multi timeframe chartsEarnings Summary Report & Fast Moving Trade Plans - newser.com
Published on: 2025-11-19 00:29:12 - newser.com
Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Applied Therapeutics Inc-Aktie (APLT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):